Noninvasive Blood Glucose Monitoring Using Otoacoustic Emissions
Recruitment status was Recruiting
The purpose of the research is to determine whether a noninvasive hearing test may be used to predict blood glucose in people with diabetes.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Noninvasive Blood Glucose Monitoring Using Otoacoustic Emissions|
- Otoacoustic emissions change with blood sugar levels [ Time Frame: One 2-hour screening visit, and on 4-hour visit ] [ Designated as safety issue: No ]
|Study Start Date:||June 2006|
|Estimated Study Completion Date:||June 2010|
|Estimated Primary Completion Date:||June 2010 (Final data collection date for primary outcome measure)|
|Non diabetic subjects|
Participation in the study will involve listening to sounds through earphones while blood glucose levels are measured by taking blood samples using a lancet. During the study, blood glucose levels will be increased by drinking a beverage containing sugar.
Up to five visits to the NCRAR will be needed over a six-month period to complete the study. Each visit lasts either two or four hours, and will be scheduled at your convenience. You will be paid $20 for the first 2-hour screening visit and $50 for each 4-hour visit. You will be paid $30 if you are selected to participate in a 2-hour Attention Correlation Test that a sub-set of 10 participants will complete.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01073137
|Contact: Peter G Jacobs, MSEE||503-220-8262 ext 55949||Peter.Jacobs@va.gov|
|United States, Oregon|
|Portland VA Medical Center||Recruiting|
|Portland, Oregon, United States, 97239|
|Contact: Peter G Jacobs, MSEE 503-220-8262 ext 55949 Peter.Jacobs@va.gov|
|Sub-Investigator: Peter G Jacobs, MSEE|
|Principal Investigator:||Eric A Wan, PhD||Oregon Health and Science University|